Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial
Article in The Lancet Infectious Diseases (January 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Article in The Lancet Infectious Diseases (January 2024)
Article in Science Translational Medicine (December 2023)
Article in Expert Opinion on Therapeutic Targets (October 2023)